$0.73
-0.01 (-1.49%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,848.8% upside
Low Target
$19.68
Average Target
$21.60
High Target
$29.43
Current Price
$0.73
Current
$0.73
$0.73
Target
$21.60
$21.60
$19.68
$21.60 avg
$29.43
Scenario Analysis
Bear Case
$19.68
2,586.7%
Low target
Base Case
$21.60
+2,848.8%
Avg target
Bull Case
$29.43
+3,917.7%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$2.42
-69.7% from high
52-Week Low
$0.72
+1.7% from low
Target vs 52W High
$21.60
+792.6% vs high
Next Earnings Report
May 20, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.28
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |